‘Mini Tumors’ from Patient Samples Could Help Personalize Cancer Drug Treatment

News   Feb 23, 2018 | Original story from ICR

 
‘Mini Tumors’ from Patient Samples Could Help Personalize Cancer Drug Treatment

Credit: ICR

 
 
 

RELATED ARTICLES

Researchers Awarded $28M for Illuminating Druggable Genome NIH Grants

News

Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.

READ MORE

PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug Discovery

News

Investment to fund expansion of operations and progression of drug target pipeline.

READ MORE

Targeting a Leaky Protein that Causes Paralysis

News

A rare genetic disorder in which people are overcome suddenly with profound muscle weakness is caused by a hole in a membrane protein that allows sodium ions to leak across cell membranes. Compounds containing a chemical group called guanidinium can block the pore created by the mutation and stop the sodium leak without altering the voltage sensor’s ability to function.

READ MORE

 

Comments | 1 ADD COMMENT

Ken Dixon | Mar 21, 2018

My name is Ken Dixon, and I am a cancer surgeon and the founder of SpeciCare (www.specicare.com), a company that provides personalized cancer care solutions. We help patients take control of their tumor tissue by storing it in multiple formats. Thank you for highlighting the advances in personalized cancer care and helping people understand the importance of NOT allowing surgeons to throw their tumor tissue away.


Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE